Single-dose brachytherapy for the palliative treatment of esophageal cancer

Endoscopy

Volumn 37, Issue 11, 2005, Pages 1143-1148

  Homs, M Y V ^a   Eijkenboom, W M H ^a   Siersema, P D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137; IRIDIUM 192;

BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DOSIMETRY; DYSPHAGIA; ENDOSCOPIC THERAPY; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS FISTULA; ESOPHAGUS HEMORRHAGE; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; HEMATEMESIS; HUMAN; INTERMETHOD COMPARISON; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION BEAM; RETROSTERNAL PAIN; REVIEW; STENT; SURVIVAL RATE; SURVIVAL TIME;

BRACHYTHERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; PALLIATIVE CARE;

EID: 27644581737     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870341     Document Type: Review

References (34)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001; 37 (Suppl 8): 4-66
2. Botterweck AA, Schouten LJ, Volovics A et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654
3. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053
4. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29
5. Sundelof M, Ye W, Dickman PW, Lagergren J. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer 2002; 99: 751-754
6. Medical Research Councel Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733
7. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2001; 4: CD001556
8. Geh JI. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002; 38: 300-313
9. Arnott SJ, Duncan W, Gignoux M et al. Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 2000; 2: CD001799
10. Stuschke M, Stahl M, Wilke H et al. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and mid-thoracic esophagus. Am J Clin Oncol 2000; 23: 233-238
11. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-2921
12. Schraube P, Fritz P, Wannenmacher MF. Combined endoluminal and external irradiation of inoperable oesophageal carcinoma. Radiother Oncol 1997; 44: 45-51
13. Taal BG, Aleman BM, Koning CC, Boot H. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer 1996; 74: 1452-1457
14. Siersema PD, Hop WC, van Blankenstein M et al. A comparison of three types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001; 54: 145-153
15. Christie NA, Buenaventura PO, Fernando HC et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up [and Discussion]. Ann Thorac Surg 2001; 71: 1797-1802
16. Kozarek RA, Raltz S, Brugge WR et al. Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheo-esophageal fistula. Gastrointest Endosc 1996; 44: 562-567
17. Hishikawa Y, Kurisu K, Taniguchi M et al. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol 1991; 21: 107-114
18. Gaspar LE, Nag S, Herskovic A et al. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys 1997; 38: 127-132
19. Rowland CG, Pagliero KM. Intracavitary irradiation in palliation of carcinoma of oesophagus and cardia. Lancet 1985; 2: 981-983
20. Brewster AE, Davidson SE, Makin WP et al. Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 1995; 7: 102-105
21. Jager J, Langendijk H, Pannebakker M et al. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol 1995; 37: 237-240
22. Kulhavy M, Sur RK, Levin CV et al. Optimization of single-fraction high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer: a preliminary report. Endocurie Hypertherm Oncol 1995; 11: 235-239
23. Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1998; 40: 447-453
24. Sur RK, Levin CV, Donde B et al. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma: an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys 2002; 53: 127-133
25. Sharma V, Mahantshetty U, Dinshaw KA et al. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2002; 52: 310-315
26. Homs MY, Eijkenboom WM, Coen VL et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol 2003; 66: 327-332
27. Homs MY, Steyerberg EW, Eijkenboom WM et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004; 364: 1497-1504
28. Nickers P, Kunkler I, Scalliet P. Modern brachytherapy: current state and future prospects. Eur J Cancer 1997, 33: 1747-1751
29. Sur R, Donde B, Falkson C et al. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy 2004; 3: 191-195
30. Sur RK, Kochhar R, Singh DP. Oral sucralfate in acute radiation oesophagitis. Acta Oncol 1994; 33: 61-63
31. Morgan RA, Ellul JP, Denton ER et al. Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology 1997; 204: 527-532
32. Siersema PD, Schrauwen SL, van Blankenstein M et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 2001; 54: 579-586
33. Dumonceau JM, Cremer M, Lalmand B, Deviere J. Esophageal fistula sealing: choice of stent, practical management, and cost. Gastrointest Endosc 1999; 49: 70-78
34. Homs MY, Steyerberg EW, Eijkenboom WMH, Siersema PD. Predictors of outcome of single dose brachytherapy for the palliation of dysphagia from esophageal cancer. In press 2005